MUNDELEIN, Ill., Sept. 27 /PRNewswire/ -- Sysmex America, Inc., already known as a world leader for its best-in-class hematology product offerings, has earned the 2006 GHX Market Intelligence Best in Class award in the Urinalysis Reagents/Supplies category. This award recognizes Sysmex for leadership in year-over-year market share increase for distributed products through 2005 year-end, said John Kershaw, President, Sysmex America. Winners were determined by analyzing national dollar volume data for product sales through the medical surgical and clinical laboratory supply chains.
“The 2006 Best in Class companies are market share leaders in their categories not only because of their sales volume, but also because they have an ongoing commitment to customer satisfaction,” says Patrick McCarthy, Executive Vice President, GHX Business Intelligence Solutions. “Many of these companies leverage superior market intelligence to better forecast growth opportunities and meet their customer needs for quality products to enhance patient care.” The data used to determine best-in-class suppliers was extracted from six report groups, including: Physician, Long Term Care, Treatment Centers, Other/Unspecified, Clinical Laboratories, and Hospital.
“While Sysmex has long been known for its advanced automated hematology analyzers, we encourage laboratories to look to us as a laboratory partner for a variety of solutions, including urinalysis. Our single-source philosophy of manufacturing and selling excellent lab instruments and the dedicated reagents used with these instruments sets us apart from our competitors. This consistent focus on excellence in product development and manufacturing underpins our activities as a manufacturer and has led to the development of high-value-added products that reflect our company’s unique strengths,” said Kershaw.
Sysmex developed the first fully automated urine cell analyzer in the world -- the UF-100(TM), making its debut in the United States in 1996. In 2003, the Sysmex UF-50(TM), a similar but smaller scale instrument, was also launched in the United States. The UF-Series Automated Urine Cell Analyzers combine the advanced technology of fluorescent flow cytometry with fully automated urine sample analysis, providing walk-away capability and standardization. The UF-100 is distributed in the United States by Sysmex, Cardinal Health Corporation and Bayer Corporation. The UF-50 is distributed by Sysmex and Cardinal Health. In Canada, the UF-Series analyzers are distributed by Somagen Diagnostics.
About GHX
Global Healthcare Exchange (GHX) provides an open and neutral electronic trading exchange, as well as complementary products and services, designed to improve the procurement-to-payment process in the healthcare supply chain; thereby improving efficiencies, automating processes and reducing operating expenses. Equity owners of GHX are Abbott Exchange, Inc.; AmerisourceBergen Corp.; Baxter Healthcare Corp.; B Braun Medical Inc.; Becton, Dickinson & Co.; Boston Scientific Corp.; Cardinal Health, Inc.; C.R. Bard, Inc.; Fisher Scientific International, Inc.; GE Healthcare; HCA; Johnson & Johnson Health Care Systems Inc.; McKesson Corp.; Medtronic USA, Inc.; Owens & Minor; Premier, Inc.; Siemens; Tyco Healthcare Group, LP; University HealthSystem Consortium; and VHA Inc. For more information, visit http://www.ghx.com/.
About Sysmex America, Inc.
Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems. Serving customers for over 35 years, Sysmex focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide. For more information about Sysmex, please visit http://www.sysmex.com/usa.
Sysmex America, Inc.
CONTACT: Tammy Kutz, Sysmex America, Inc., +1-847-996-4531,kutzt@sysmex.com
